We were able to demonstrate that the GSI RO4929097 targets an unexpected non-canonical tumor-suppressing NOTCH3 activity, which is involved in spontaneous as well as gliotoxin-induced apoptosis in CLL cells. This evidence concerns the gene NOTCH3 and B-cell chronic lymphocytic leukemia.